Trials / Sponsors / Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | A Study of Chenodeoxycholic Acid (CDCA) in Newly Diagnosed Participants With Cerebrotendinous Xanthomatosis (C Cerebrotendinous Xanthomatoses | Phase 3 | 2024-05-27 |
| Active Not Recruiting | Multi-Center Study of ManNAc for GNE Myopathy GNE Myopathy | Phase 2 | 2022-04-05 |
| Completed | STP206 for the Prevention of Necrotizing Enterocolitis (NEC) Necrotizing Enterocolitis | Phase 1 | 2014-01-30 |
| Completed | EZN-2279 in Patients With ADA-SCID ADA-SCID, Adenosine Deaminase Deficiency, Severe Combined Immunodeficiency | Phase 3 | 2014-01-24 |
| Completed | Safety and Tolerability of STP206 in Healthy Adult Subjects Healthy | Phase 1 | 2010-03-01 |